𝔖 Bobbio Scriptorium
✦   LIBER   ✦

Flow-cytometric analysis of apoptotic and nonapoptotic T-cell receptor-transgenic thymocytes following in vitro presentation of antigen

✍ Scribed by S. J. Curnow; M. Barad; N. Brun-Roubereau; A.-M. Schmitt-Verhulst


Book ID
102813720
Publisher
John Wiley and Sons
Year
1994
Tongue
English
Weight
757 KB
Volume
16
Category
Article
ISSN
0196-4763

No coin nor oath required. For personal study only.

✦ Synopsis


Abstract

The use of flow cytometry to detect apoptotic thymocytes is now well established. We have further developed the technique of Hoechst 33342 vital staining to identify discrete stages of murine thymocyte apoptosis (induced by 37°C culture), in conjunction with propidium iodide (PI), cell scatter profile, and surface marker analysis. The first detectable stage was an increase in Hoechst fluorescence without any change in plasma membrane permeability (measured by PI staining). At this early stage thymocytes had already reduced in size, fragmented their DNA, and for the predominant CD4^+^ CD8^+^ double positive population, reduced expression of CD4 and CD8. Subsequent to this stage thymocytes continued to reduce in size and decrease expression of CD4 and CD8, though this was accompanied by an increase in membrane permeability. This technique was applied to an in vitro antigen‐specific deletion system, where apoptosis of T cell‐receptor‐transgenic thymocytes was induced upon presentation of self‐antigen. Although self‐antigen‐induced apoptotic thymocytes showed similar characteristics to those undergoing spontaneous apoptosis, there was a significant population of nonapoptotic CD4^+^8^+^ thymocytes that also had reduced expression of CD4 and CD8. Therefore, we have been able to show that the reduced expression of CD4 and CD8 is not limited to apoptotic thymocytes. © 1994 Wiley‐Liss, Inc.


📜 SIMILAR VOLUMES


Flow cytometric analysis of the expressi
✍ Ryuichi Fukuyama; Shinsei Minoshima; Atsushi Ochiai; Eiichi Tahara; Nobuyoshi Sh 📂 Article 📅 2007 🏛 John Wiley and Sons 🌐 French ⚖ 812 KB

We have previously produced a monoclonal antibody (MAb) against TMK-I cells, a poorly differentiated stomach-cancer cell line, and designated the antigen as 9A3. Immunohistochemical analysis of various tumor tissues revealed that the expression of 9A3 antigen is specific for human adenocarcinomz In